-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $3 Price Target

Benzinga·06/03/2025 11:23:55
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains $3 price target.